PortfoliosLab logoPortfoliosLab logo
GRC vs. JNJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GRC vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Gorman-Rupp Company (GRC) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GRC achieves a 70.94% return, which is significantly higher than JNJ's 25.25% return. Over the past 10 years, GRC has outperformed JNJ with an annualized return of 14.38%, while JNJ has yielded a comparatively lower 10.44% annualized return.


GRC

1D
0.62%
1M
-8.49%
6M
49.80%
YTD
70.94%
1Y
100.02%
3Y*
38.18%
5Y*
20.22%
10Y*
14.38%
ALL TIME*
11.19%

JNJ

1D
0.21%
1M
0.93%
6M
14.06%
YTD
25.25%
1Y
59.50%
3Y*
18.33%
5Y*
11.37%
10Y*
10.44%
ALL TIME*
12.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$19.01M$17.85M$14.41M
$2.09B$2.09B$1.99B

GRC vs. JNJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GRC
The Gorman-Rupp Company
70.94%28.24%8.87%42.15%-41.17%39.71%-11.90%17.64%11.75%2.49%
JNJ
Johnson & Johnson
25.25%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%

Correlation

The correlation between GRC and JNJ is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.07

Correlation (3Y)
Balances recent behavior with more history.

0.06

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.12

Correlation (10Y)
Provides a long-term view across more market conditions.

0.19

Correlation (All Time)
Calculated using the full available price history since Mar 17, 1992

0.20

The correlation between GRC and JNJ shifts across timeframes, from 0.06 (3 years) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GRC:

$2.14B

JNJ:

$617.78B

EPS

GRC:

$2.37

JNJ:

$8.63

PE Ratio

GRC:

34.27

JNJ:

29.71

PEG Ratio

GRC:

0.70

JNJ:

0.99

PS Ratio

GRC:

3.04

JNJ:

6.38

PB Ratio

GRC:

4.85

JNJ:

7.36

Total Revenue (TTM)

GRC:

$702.05M

JNJ:

$97.93B

Gross Profit (TTM)

GRC:

$214.56M

JNJ:

$68.99B

EBITDA (TTM)

GRC:

$129.99M

JNJ:

$31.92B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GRC vs. JNJ — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GRC
GRC Risk / Return Rank: 9696
Overall Rank
GRC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
GRC Sortino Ratio Rank: 9696
Sortino Ratio Rank
GRC Omega Ratio Rank: 9494
Omega Ratio Rank
GRC Calmar Ratio Rank: 9797
Calmar Ratio Rank
GRC Martin Ratio Rank: 9797
Martin Ratio Rank

JNJ
JNJ Risk / Return Rank: 9797
Overall Rank
JNJ Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9797
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9696
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GRC vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Gorman-Rupp Company (GRC) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GRCJNJDifference
Sharpe ratioReturn per unit of total volatility

-0.45

Sortino ratioReturn per unit of downside risk

-0.66

Omega ratioGain probability vs. loss probability

1.44

1.56

-0.11

Calmar ratioReturn relative to maximum drawdown

6.75

5.46

+1.29

Martin ratioReturn relative to average drawdown

17.21

15.18

+2.03

GRC vs. JNJ - Sharpe Ratio Comparison

The current GRC Sharpe Ratio is 2.81, which is comparable to the JNJ Sharpe Ratio of 3.26. The chart below compares the historical Sharpe Ratios of GRC and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GRC vs. JNJ - Drawdown Comparison

The maximum GRC drawdown since its inception was -67.23%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for GRC and JNJ.


Loading charts...

Drawdown Indicators


GRCJNJDifference

Max Drawdown

Largest peak-to-trough decline

-67.23%

-50.67%

-16.56%

Max Drawdown (1Y)

Largest decline over 1 year

-14.90%

-10.96%

-3.94%

Max Drawdown (3Y)

Largest decline over 3 years

-26.87%

-15.72%

-11.15%

Max Drawdown (5Y)

Largest decline over 5 years

-49.26%

-18.41%

-30.85%

Max Drawdown (10Y)

Largest decline over 10 years

-49.26%

-27.37%

-21.89%

Current Drawdown

Current decline from peak

-11.50%

-4.07%

-7.43%

Average Drawdown

Average peak-to-trough decline

-17.59%

-11.88%

-5.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.83%

3.93%

+1.90%

Volatility

GRC vs. JNJ - Volatility Comparison

The Gorman-Rupp Company (GRC) has a higher volatility of 12.13% compared to Johnson & Johnson (JNJ) at 8.48%. This indicates that GRC's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GRCJNJDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.13%

8.48%

+3.65%

Volatility (6M)

Calculated over the trailing 6-month period

30.07%

15.03%

+15.04%

Volatility (1Y)

Calculated over the trailing 1-year period

35.80%

18.44%

+17.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.19%

17.46%

+13.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.00%

18.75%

+15.25%

Dividends

GRC vs. JNJ - Dividend Comparison

GRC's dividend yield for the trailing twelve months is around 0.93%, less than JNJ's 2.04% yield.


PositionTTM20252024202320222021202020192018201720162015
GRC
The Gorman-Rupp Company
0.93%1.56%1.91%1.98%2.67%1.43%1.82%1.47%7.74%1.51%1.39%1.52%
JNJ
Johnson & Johnson
2.04%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%

Financials

GRC vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between The Gorman-Rupp Company and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

GRC vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between The Gorman-Rupp Company and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

GRC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Gorman-Rupp Company reported a gross profit of 63.69M and revenue of 186.07M. Therefore, the gross margin over that period was 34.2%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported a gross profit of 18.50B and revenue of 25.31B. Therefore, the gross margin over that period was 73.1%.

GRC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Gorman-Rupp Company reported an operating income of 30.41M and revenue of 186.07M, resulting in an operating margin of 16.3%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported an operating income of 7.17B and revenue of 25.31B, resulting in an operating margin of 28.3%.

GRC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Gorman-Rupp Company reported a net income of 19.43M and revenue of 186.07M, resulting in a net margin of 10.4%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported a net income of 5.53B and revenue of 25.31B, resulting in a net margin of 21.9%.


Frequently Asked Questions


GRC and JNJ have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GRC has higher volatility (12.13%) compared to JNJ (8.48%). In terms of maximum drawdown, GRC dropped -67.23% vs JNJ's -50.67%.

JNJ currently has the higher Sharpe Ratio (3.26 vs 2.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GRC and JNJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer